SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

A fair growth of 19.39% in the revenue at Rs. 732.66 millions was reported in the March 2024 quarter as compared to Rs. 613.69 millions during year-ago period.A slender decline of -20.30% was recorded to Rs. 67.47  millions from Rs. 84.66 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 116.75 millions from 127.17 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 732.66 613.69 19.39 2583.60 2246.44 15.01 2583.60 2246.44 15.01
Other Income 28.71 67.79 -57.65 131.01 146.10 -10.33 131.01 146.10 -10.33
PBIDT 116.75 127.17 -8.19 409.55 342.22 19.67 409.55 342.22 19.67
Interest 11.70 12.92 -9.44 44.49 31.30 42.14 44.49 31.30 42.14
PBDT 105.05 114.38 -8.16 364.82 311.05 17.29 364.82 311.05 17.29
Depreciation 12.98 11.68 11.13 47.22 45.39 4.03 47.22 45.39 4.03
PBT 92.07 102.70 -10.35 317.60 265.66 19.55 317.60 265.66 19.55
TAX 24.60 18.04 36.36 81.36 64.95 25.27 81.36 64.95 25.27
Deferred Tax 0.43 -7.84 -105.48 5.54 -1.53 -462.09 5.54 -1.53 -462.09
PAT 67.47 84.66 -20.30 236.24 200.71 17.70 236.24 200.71 17.70
Equity 940.00 940.00 0.00 940.00 940.00 0.00 940.00 940.00 0.00
PBIDTM(%) 15.94 20.72 -23.10 15.85 15.23 4.06 15.85 15.23 4.06

Syncom Formulations Share Price

13.46 -0.43 (-3.10%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×